Alternative approaches for identifying acute systemic toxicity: Moving from research to regulatory testing.

Acute systemic toxicity testing provides the basis for hazard labeling and risk management of chemicals. A number of international efforts have been directed at identifying non-animal alternatives for in vivo acute systemic toxicity tests. A September 2015 workshop, Alternative Approaches for Identifying Acute Systemic Toxicity: Moving from Research to Regulatory Testing, reviewed the state-of-the-science of non-animal alternatives for this testing and explored ways to facilitate implementation of alternatives. Workshop attendees included representatives from international regulatory agencies, academia, nongovernmental organizations, and industry. Resources identified as necessary for meaningful progress in implementing alternatives included compiling and making available high-quality reference data, training on use and interpretation of in vitro and in silico approaches, and global harmonization of testing requirements. Attendees particularly noted the need to characterize variability in reference data to evaluate new approaches. They also noted the importance of understanding the mechanisms of acute toxicity, which could be facilitated by the development of adverse outcome pathways. Workshop breakout groups explored different approaches to reducing or replacing animal use for acute toxicity testing, with each group crafting a roadmap and strategy to accomplish near-term progress. The workshop steering committee has organized efforts to implement the recommendations of the workshop participants.

[1]  Ruili Huang,et al.  The Tox21 robotic platform for the assessment of environmental chemicals--from vision to reality. , 2013, Drug discovery today.

[2]  A. Kopp-Schneider,et al.  Evaluation of aggregating brain cell cultures for the detection of acute organ-specific toxicity. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[3]  Hans Raabe,et al.  Assessment of the predictive capacity of the 3T3 Neutral Red Uptake cytotoxicity test method to identify substances not classified for acute oral toxicity (LD50>2000 mg/kg): results of an ECVAM validation study. , 2013, Regulatory toxicology and pharmacology : RTP.

[4]  C. Austin,et al.  Improving the Human Hazard Characterization of Chemicals: A Tox21 Update , 2013, Environmental health perspectives.

[5]  B. Isomaa,et al.  MEIC Evaluation of Acute Systemic Toxicity: Part VI. The Prediction of Human Toxicity by Rodent LD50 Values and Results From 61 In Vitro Methods. , 1998, Alternatives to laboratory animals : ATLA.

[6]  Daniel L Villeneuve,et al.  Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment , 2010, Environmental toxicology and chemistry.

[7]  Daniel M. Wilson,et al.  Acute Toxicity Prediction in Multiple Species by Leveraging Mechanistic ToxCast Mitochondrial Inhibition Data and Simulation of Oral Bioavailability. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[8]  Ian Indans,et al.  Acute toxicity testing of chemicals—Opportunities to avoid redundant testing and use alternative approaches , 2010, Critical reviews in toxicology.

[9]  Stephen W. Edwards,et al.  Integrating Publicly Available Data to Generate Computationally Predicted Adverse Outcome Pathways for Fatty Liver. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.

[10]  Sebastian Hoffmann,et al.  Estimation of acute oral toxicity using the No Observed Adverse Effect Level (NOAEL) from the 28 day repeated dose toxicity studies in rats. , 2009, Regulatory toxicology and pharmacology : RTP.

[11]  Andrew Worth,et al.  Metabolism: A Bottleneck in In Vitro Toxicological Test Development , 2006, Alternatives to laboratory animals : ATLA.

[12]  Yu-Mei Tan,et al.  Adverse Outcome Pathways—Organizing Toxicological Information to Improve Decision Making , 2016, The Journal of Pharmacology and Experimental Therapeutics.

[13]  A Kopp-Schneider,et al.  Selection of test methods to be included in a testing strategy to predict acute oral toxicity: an approach based on statistical analysis of data collected in phase 1 of the ACuteTox project. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[14]  David M. Reif,et al.  Zebrafish developmental screening of the ToxCast™ Phase I chemical library. , 2012, Reproductive toxicology.

[15]  Annette Kopp-Schneider,et al.  Design of a testing strategy using non-animal based test methods: lessons learnt from the ACuteTox project. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[16]  Bas J Blaauboer,et al.  Dose metric considerations in in vitro assays to improve quantitative in vitro-in vivo dose extrapolations. , 2015, Toxicology.

[17]  Troy Seidle,et al.  Examining the regulatory value of multi-route mammalian acute systemic toxicity studies. , 2011, ALTEX.

[18]  David M. Reif,et al.  In Vitro Screening of Environmental Chemicals for Targeted Testing Prioritization: The ToxCast Project , 2009, Environmental health perspectives.

[19]  Andrew P. Worth,et al.  EURL ECVAM strategy for achieving 3Rs impact in the assessment of toxicokinetics and systemic toxicity , 2015 .

[20]  Ruili Huang,et al.  Modelling the Tox21 10 K chemical profiles for in vivo toxicity prediction and mechanism characterization , 2016, Nature Communications.

[21]  David M. Reif,et al.  Comparison of toxicity values across zebrafish early life stages and mammalian studies: Implications for chemical testing. , 2015, Reproductive toxicology.

[22]  A Kopp-Schneider,et al.  The value of selected in vitro and in silico methods to predict acute oral toxicity in a regulatory context: results from the European Project ACuteTox. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[23]  Shannon M. Bell,et al.  Accelerating Adverse Outcome Pathway Development Using Publicly Available Data Sources , 2016, Current Environmental Health Reports.

[24]  Hao Zhu,et al.  Profiling Animal Toxicants by Automatically Mining Public Bioassay Data: A Big Data Approach for Computational Toxicology , 2014, PloS one.

[25]  Bas J Blaauboer,et al.  The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans. , 2012, ALTEX.

[26]  J Scheel,et al.  Report from the EPAA workshop: in vitro ADME in safety testing used by EPAA industry sectors. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[27]  Ruili Huang,et al.  Application of a homogenous membrane potential assay to assess mitochondrial function. , 2012, Physiological genomics.

[28]  R. Graepel,et al.  Exploring Waiving Opportunities for Mammalian Acute Systemic Toxicity Tests , 2016, Alternatives to laboratory animals : ATLA.

[29]  Ruili Huang,et al.  Mechanism Profiling of Hepatotoxicity Caused by Oxidative Stress Using Antioxidant Response Element Reporter Gene Assay Models and Big Data , 2015, Environmental health perspectives.

[30]  Hao Zhu,et al.  Big Data in Chemical Toxicity Research: The Use of High-Throughput Screening Assays To Identify Potential Toxicants , 2014, Chemical research in toxicology.

[31]  Demetrio Raldúa,et al.  Zebrafish Models for Human Acute Organophosphorus Poisoning , 2015, Scientific Reports.

[32]  Price Anna,et al.  EURL ECVAM strategy to replace, reduce and refine the use of animals in the assessment of acute mammalian systemic toxicity , 2014 .

[33]  E. W. Morris No , 1923, The Hospital and health review.

[34]  Carlie A. LaLone,et al.  Development of an adverse outcome pathway for acetylcholinesterase inhibition leading to acute mortality , 2014, Environmental toxicology and chemistry.

[35]  J. Bueren,et al.  In vitro sensitivity of granulo-monocytic progenitors as a new toxicological cell system and endpoint in the ACuteTox Project. , 2009, Toxicology and applied pharmacology.

[36]  Ruili Huang,et al.  Profiling of the Tox21 Chemical Collection for Mitochondrial Function to Identify Compounds that Acutely Decrease Mitochondrial Membrane Potential , 2014, Environmental health perspectives.

[37]  Ruth A. Roberts,et al.  Development and use of in vitro alternatives to animal testing by the pharmaceutical industry 1980–2013 , 2015 .

[38]  J. Hermens,et al.  Estimating Acute Toxicity Based on In Vitro Cytotoxicity: Role of Biokinetic Modelling , 2005 .

[39]  David Dreher,et al.  Can acute dermal systemic toxicity tests be replaced with oral tests? A comparison of route-specific systemic toxicity and hazard classifications under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS). , 2013, Regulatory toxicology and pharmacology : RTP.

[40]  Daniel P. Russo,et al.  Global Analysis of Publicly Available Safety Data for 9,801 Substances Registered under REACH from 2008–2014 , 2016, ALTEX.

[41]  Sally Robinson,et al.  Cross-Sector Review of Drivers and Available 3Rs Approaches for Acute Systemic Toxicity Testing , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[42]  B. Blaauboer An in vitro test strategy for predicting human acute toxicity , 2009 .

[43]  Helmut Segner,et al.  MEIC Evaluation of Acute Systemic Toxicity , 1998 .